Results 101 to 110 of about 34,481 (211)

Transdermal delivery of metoprolol by electroporation

open access: yes, 1994
Electroporation, i.e., the creation of transient "pores" in lipid membranes leading to increased permeability, could be used to promote transdermal drug delivery.
Vanbever, Rita   +2 more
core   +1 more source

Image_3_Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug.tif

open access: yes, 2018
Metoprolol is used for phenotyping of cytochrome P450 (CYP) 2D6, a CYP isoform considered not to be inducible by inducers of the CYP2C, CYP2B, and CYP3A families such as rifampicin.
Benjamin Berger (3704707)   +4 more
core   +1 more source

The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure

open access: yes, 2006
Ovidio De Freitas, Oliver Lenz, Alessia Fornoni, Barry J MatersonDivision of Nephrology and Hypertension, Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida, USAAbstract: About 5 million Americans suffer from heart ...
Oliver Lenz   +7 more
core  

Dilitiazem in Comparison with metoprolol in stable angina pectoris

open access: yes, 1988
The efficacy of diltiazem in comparison with metoprolol in chronic stable angina was assessed in 33 male patients during a 15-week blind cross-over study. After an initial two-week run-in period, baseline measurements were made.
Van Dijk, R. B.   +2 more
core   +1 more source

Effect of metoprolol in patients with renal hypertension [PDF]

open access: yes, 1988
Eighteen patients with renal hypertension were treated with metoprolol (Seloken) for more than 3 months. Compared with the pretreatment value, the mean blood pressure decreased by 6.0, 11.2, 9.2 and 12.2 mmHg, after 2 weeks and 3, 6 and 12 months of ...
西阪, 誠泰   +8 more
core  

Effectiveness of Metoprolol in Improving Cardiac and Motor Functions in Patients with Chronic Heart Failure: A Prospective Study

open access: yesDrug Design, Development and Therapy, 2020
XiaoLiang Cheng,1 Min Zhu,2 Qing Liu,3 Zhenxia Feng,2 Yong Meng2 1Department of Endocrinology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People’s Republic of China; 2Department of Cardiology, The Second ...
Cheng X, Zhu M, Liu Q, Feng Z, Meng Y
doaj  

Factors affecting iontophoretic mobility of metoprolol.

open access: yes, 1992
The effect of different factors on the iontophoretic transport of metoprolol was analyzed. In vitro experiments were first performed in a diffusion cell with a cellophane membrane.
Thysman, S.   +2 more
core   +1 more source

Features of anti-ischemic efficacy of trimetazidine MR, assigned in combination with metoprolol in patients with angina

open access: yesКардиоСоматика, 2013
We studied the influence of trimetazidine MR on exercise tolerance and carbohydrate metabolism in 28 patients with stable effort angina, treated with metoprolol.
P. Yu Bardybakhin   +2 more
doaj  

Metoprolol succinate (CR/XL): Advanced formulation of classical b-blocker

open access: yes, 2020
Metoprolol is a selective beta(1)-adrenergic antagonist extensively used in major fields of cardiology since 1975. Metoprolol has proven its efficacy in reducing cardiovascular events and mortality in patients with hypertension and coronary heart disease
Gudkov K.M., Kobalava Z.D.
core  

Influence of pentobarbital on metoprolol plasma levels

open access: yes, 1979
Induction of microsomal enzymes with barbiturates in rats has little effect on the metabolism of metoprolol, compared with propranolol and alprenolol, which undergo extensive hepatic extraction in animals and man.
Borg, KO   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy